X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (64255) 64255
Book Chapter (196) 196
Newsletter (178) 178
Newspaper Article (102) 102
Magazine Article (83) 83
Dissertation (22) 22
Book / eBook (16) 16
Transcript (15) 15
Reference (11) 11
Publication (8) 8
Conference Proceeding (7) 7
Government Document (6) 6
Book Review (5) 5
Report (4) 4
Web Resource (3) 3
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45411) 45411
animals (30048) 30048
female (25205) 25205
male (24850) 24850
mice (16056) 16056
recombinant proteins (14687) 14687
middle aged (12812) 12812
adult (12610) 12610
recombinant proteins - administration & dosage (10958) 10958
recombinant proteins - therapeutic use (10077) 10077
aged (8597) 8597
immunology (8436) 8436
treatment outcome (7476) 7476
recombinant proteins - pharmacology (7313) 7313
rats (6599) 6599
oncology (6222) 6222
expression (6073) 6073
proteins (6008) 6008
hematology (5558) 5558
medicine, research & experimental (5085) 5085
pharmacology & pharmacy (5006) 5006
research (4760) 4760
dose-response relationship, drug (4569) 4569
time factors (4537) 4537
therapy (4533) 4533
health aspects (4495) 4495
analysis (4384) 4384
mice, inbred balb c (4306) 4306
mice, inbred c57bl (4194) 4194
biochemistry & molecular biology (4117) 4117
biotechnology & applied microbiology (4089) 4089
recombinant proteins - metabolism (4065) 4065
interferon-alpha - administration & dosage (3914) 3914
recombinant proteins - genetics (3896) 3896
cancer (3857) 3857
disease models, animal (3762) 3762
adolescent (3722) 3722
care and treatment (3670) 3670
drug therapy, combination (3552) 3552
gene expression (3534) 3534
drug administration schedule (3322) 3322
recombinant proteins - immunology (3275) 3275
cell biology (3197) 3197
interferon-alpha - therapeutic use (3160) 3160
cells (3148) 3148
vaccines (3124) 3124
recombinant fusion proteins - genetics (3067) 3067
recombinant proteins - adverse effects (3035) 3035
research article (2987) 2987
cells, cultured (2925) 2925
antibodies (2921) 2921
in-vivo (2868) 2868
physiological aspects (2744) 2744
multidisciplinary sciences (2689) 2689
immunization (2672) 2672
cell line (2637) 2637
endocrinology & metabolism (2599) 2599
recombinant fusion proteins - administration & dosage (2534) 2534
immunotherapy (2498) 2498
surgery (2488) 2488
erythropoietin - therapeutic use (2477) 2477
antigens (2474) 2474
microbiology (2434) 2434
infection (2373) 2373
child (2341) 2341
medicine (2318) 2318
hepatitis c, chronic - drug therapy (2287) 2287
infectious diseases (2283) 2283
molecular sequence data (2247) 2247
vaccination (2217) 2217
rats, sprague-dawley (2214) 2214
interferon (2196) 2196
cytokines (2146) 2146
erythropoietin (2146) 2146
erythropoietin - administration & dosage (2094) 2094
apoptosis (2073) 2073
aged, 80 and over (2043) 2043
protein (2043) 2043
injections, subcutaneous (2029) 2029
recombinant fusion proteins - immunology (2029) 2029
prospective studies (2000) 2000
amino acid sequence (1998) 1998
medicine & public health (1998) 1998
antiviral agents - therapeutic use (1993) 1993
recombinant fusion proteins - metabolism (1991) 1991
antineoplastic combined chemotherapy protocols - therapeutic use (1956) 1956
gastroenterology & hepatology (1928) 1928
antiviral agents - administration & dosage (1925) 1925
recombinant fusion proteins - therapeutic use (1912) 1912
efficacy (1901) 1901
retrospective studies (1900) 1900
drug therapy (1890) 1890
anemia (1869) 1869
chemotherapy (1851) 1851
enzyme-linked immunosorbent assay (1846) 1846
cell line, tumor (1830) 1830
recombinant proteins - chemistry (1823) 1823
genetic vectors (1785) 1785
transplantation (1762) 1762
inflammation (1722) 1722
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (63212) 63212
Japanese (719) 719
German (486) 486
Chinese (374) 374
Russian (290) 290
French (241) 241
Spanish (228) 228
Polish (114) 114
Portuguese (96) 96
Italian (86) 86
Hungarian (44) 44
Czech (29) 29
Serbian (27) 27
Korean (24) 24
Dutch (23) 23
Bulgarian (15) 15
Danish (15) 15
Croatian (12) 12
Norwegian (11) 11
Ukrainian (10) 10
Slovak (8) 8
Swedish (7) 7
Hebrew (6) 6
Turkish (4) 4
Arabic (3) 3
Lithuanian (3) 3
Romanian (2) 2
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Persian (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Archives of Allergy and Immunology, ISSN 1018-2438, 04/2015, Volume 166, Issue 1, pp. 41 - 51
Background: The FAST (food allergy-specific immunotherapy) project aims at developing safe and effective subcutaneous immunotherapy for fish allergy, using... 
Original Paper | Food allergy | Carp | Toxicity | Immunotherapy | Fish | Cyprinus carpio | Allergen mutants | FAST | Parvalbumin | Recombinant hypoallergenic allergens | TOLERANCE INDUCTION | EFFICACY | SAFETY | IGE | DESENSITIZATION | VACCINATION | IMMUNOLOGY | PEANUT ORAL IMMUNOTHERAPY | ALLERGY | PURIFICATION | CALCIUM-BINDING | HYPERSENSITIVITY | Immunoglobulin G - blood | Humans | Male | Immunoglobulin E - blood | Allergens - administration & dosage | Fish Proteins - genetics | Food Hypersensitivity - immunology | Allergens - immunology | Calcium-Binding Proteins - immunology | Injections, Subcutaneous | Leukocytes, Mononuclear - immunology | Allergens - chemistry | Escherichia coli - metabolism | Parvalbumins - genetics | Female | Protein Stability | Calcium-Binding Proteins - chemistry | Rabbits | Gene Expression | Double-Blind Method | Fish Proteins - chemistry | Fish Proteins - immunology | Parvalbumins - chemistry | Recombinant Proteins - chemistry | Allergens - genetics | Recombinant Proteins - genetics | Lethal Dose 50 | Parvalbumins - immunology | Protein Folding | Recombinant Proteins - administration & dosage | Calcium-Binding Proteins - administration & dosage | Carps - immunology | Fish Proteins - administration & dosage | Leukocytes, Mononuclear - pathology | Parvalbumins - administration & dosage | Animals | Recombinant Proteins - immunology | Escherichia coli - genetics | Food Hypersensitivity - prevention & control | Mice | Food Hypersensitivity - physiopathology | Calcium-Binding Proteins - genetics | Desensitization, Immunologic - methods | Food allergies
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2016, Volume 113, Issue 11, pp. 2868 - 2873
A central challenge to the development of protein-based therapeutics is the inefficiency of delivery of protein cargo across the mammalian cell membrane, including escape from endosomes... 
Protein delivery | Genome editing | CRISPR/Cas9 | Cre recombinase | Lipid nanoparticle | THERAPEUTICS | genome editing | COMBINATORIAL LIBRARY | VIVO | RNA | CELLS IN-VITRO | CAS9 PROTEIN | TRANSFECTION | MULTIDISCIPLINARY SCIENCES | CANCER-THERAPY | lipid nanoparticle | protein delivery | INTRACELLULAR DELIVERY | Endonucleases - genetics | Thalamus - metabolism | Nanoparticles - chemistry | Humans | Green Fluorescent Proteins - genetics | Structure-Activity Relationship | Recombinant Proteins - biosynthesis | Endosomes - metabolism | Drug Carriers | Luminescent Proteins - biosynthesis | RNA - genetics | Cholesterol - chemistry | Endocytosis | Lipids - chemistry | Integrases - administration & dosage | Endonucleases - administration & dosage | Recombination, Genetic | Nanoparticles - metabolism | Molecular Structure | Genes, Reporter | Genetic Engineering - methods | Bacterial Proteins - genetics | Genes, Synthetic | Ceramides - chemistry | Lipids - administration & dosage | Gene Knockout Techniques | Static Electricity | Nanoparticles - toxicity | Bacterial Proteins - administration & dosage | Animals | Hypothalamus - metabolism | Lipids - chemical synthesis | Green Fluorescent Proteins - biosynthesis | CRISPR-Cas Systems | Luminescent Proteins - genetics | Mice | Nanoparticles - administration & dosage | HeLa Cells | Integrases - genetics | Phosphatidylethanolamines - chemistry | Nanoparticles | Genetic aspects | Nucleotide sequencing | Lipid metabolism | Health aspects | Methods | DNA sequencing | CRISPR | Physical Sciences | Cas9
Journal Article
PLoS pathogens, ISSN 1553-7374, 2015, Volume 11, Issue 5, p. e1004896
.... The receptor for ETX is unknown. Here we show that both binding of ETX to mammalian cells and cytotoxicity requires the tetraspan proteolipid Myelin and Lymphocyte protein (MAL... 
LAMBDA-TOXIN | MDCK CELLS | BETA-TOXIN | MICROBIOLOGY | MICROVASCULAR DAMAGE | PLASMA-MEMBRANE | INTESTINAL INFECTIONS | DARBY CANINE KIDNEY | VIROLOGY | APICAL SORTING MACHINERY | RAFT-ASSOCIATED PROTEIN | PARASITOLOGY | INFLUENZA-VIRUS HEMAGGLUTININ | Injections, Intravenous | Cricetulus | Myelin and Lymphocyte-Associated Proteolipid Proteins - metabolism | Humans | Bacterial Toxins - toxicity | Recombinant Fusion Proteins - metabolism | Tissue Distribution | Protein Precursors - toxicity | Bacterial Toxins - genetics | Clostridium perfringens - metabolism | Protein Interaction Domains and Motifs | Cell Death - drug effects | Binding Sites | Clostridium perfringens - pathogenicity | Recombinant Fusion Proteins - administration & dosage | CHO Cells | Recombinant Proteins - metabolism | Protein Precursors - genetics | Protein Precursors - administration & dosage | Mice, Inbred C57BL | Rats | Recombinant Proteins - chemistry | Recombinant Fusion Proteins - toxicity | Recombinant Fusion Proteins - chemistry | Recombinant Proteins - administration & dosage | Mice, Knockout | Protein Precursors - metabolism | Toxicokinetics | Bacterial Toxins - metabolism | Animals | Myelin and Lymphocyte-Associated Proteolipid Proteins - chemistry | Recombinant Proteins - toxicity | Ligands | Mutagenesis, Insertional | Myelin and Lymphocyte-Associated Proteolipid Proteins - genetics
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 22, pp. 2055 - 2064
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 6, pp. 1114 - 1122
Background & Aims BI201335 is a highly specific and potent HCV protease inhibitor. This multiple rising dose trial evaluated antiviral activity and safety in... 
Gastroenterology and Hepatology | Antiviral | Resistant variants | Hepatitis C virus | Pegylated interferon | Ribavirin | PLUS RIBAVIRIN | BILN-2061 | TELAPREVIR | EFFICACY | VX-950 | HEPATITIS-C-VIRUS | IN-VITRO | EARLY ANTIVIRAL ACTIVITY | PEGINTERFERON ALPHA-2A | ATAZANAVIR | GASTROENTEROLOGY & HEPATOLOGY | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Protease Inhibitors - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Male | Thiazoles - administration & dosage | Recombinant Proteins | Oligopeptides - adverse effects | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Protease Inhibitors - pharmacology | Hepatitis C - blood | Ribavirin - administration & dosage | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Double-Blind Method | Oligopeptides - pharmacokinetics | Carrier Proteins - antagonists & inhibitors | Viral Nonstructural Proteins - genetics | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Drug Resistance, Viral - genetics | Hepacivirus - enzymology | Antiviral Agents - adverse effects | Hepatitis C - virology | Oligopeptides - administration & dosage | Thiazoles - pharmacology | Oligopeptides - pharmacology | Viral Load - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Medical colleges | Antiviral agents | Care and treatment | Safety and security measures | Hotels and motels | Immunodeficiency | Aspartate | Biological response modifiers | HIV (Viruses) | Anti-HIV agents | Complications and side effects | Protease inhibitors | Proteases | Genetic aspects | Hepatitis C | Viral Nonstructural Proteins | Oligopeptides | Polyethylene Glycols | Interferon-alpha | Protease Inhibitors | Drug Resistance, Viral | Antiviral Agents | Viral Load | Life Sciences | Thiazoles | Hepacivirus | Carrier Proteins | Cancer
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2015, Volume 112, Issue 2, pp. E156 - E165
.... Here we describe the use of synthetic, biodegradable nanoparticles carrying either protein or peptide antigens and a tolerogenic immunomodulator, rapamycin, to induce durable and antigen-specific... 
Nanoparticles | Rapamycin | Anti-drug antibodies | Immune tolerance | Immunotherapy | THERAPEUTICS | anti-drug antibodies | IMMUNITY | TOLEROGENIC DENDRITIC CELLS | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | FACTOR-VIII | MECHANISMS | RESPONSES | immune tolerance | IMMUNOGENICITY | nanoparticles | UNRESPONSIVENESS | immunotherapy | rapamycin | Factor VIII - immunology | Oligodeoxyribonucleotides - administration & dosage | Nanoparticles - chemistry | Ovalbumin - immunology | Immunosuppression - methods | Nanocapsules - administration & dosage | Humans | Encephalomyelitis, Autoimmune, Experimental - immunology | Hypersensitivity, Delayed - immunology | Nanocapsules - chemistry | Peptides - administration & dosage | Antigens - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Immunity, Humoral | Peptide Fragments - immunology | Proteins - administration & dosage | Female | Immunosuppressive Agents - administration & dosage | Disease Models, Animal | Lactic Acid - chemistry | Peptides - chemistry | Hemophilia A - immunology | Peptide Fragments - administration & dosage | Peptides - immunology | Immune Tolerance | Hemophilia A - therapy | Hypersensitivity, Delayed - therapy | Antigens - chemistry | Proteins - immunology | Encephalomyelitis, Autoimmune, Experimental - therapy | Sirolimus - administration & dosage | Animals | Ovalbumin - administration & dosage | Recombinant Proteins - immunology | Polyglycolic Acid - chemistry | Encephalomyelitis, Autoimmune, Experimental - prevention & control | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Hemocyanins - administration & dosage | Proteins - chemistry | Antigens | Usage | Research | Health aspects | Immunological tolerance | Immunological research | Biological Sciences | PNAS Plus
Journal Article
The Journal of Immunology, ISSN 0022-1767, 05/2004, Volume 172, Issue 10, pp. 6167 - 6174
A Plasmodium falciparum chimeric protein 2.9 (PfCP-2.9) was constructed consisting of the C-terminal regions of two leading malaria vaccine candidates, domain III of apical membrane ag-1 (AMA-1... 
APICAL MEMBRANE ANTIGEN-1 | C-TERMINAL FRAGMENT | PROTECTS AOTUS MONKEYS | IMMUNITY | IMMUNIZATION | INVASION | MEROZOITE SURFACE PROTEIN-1 | PLASMODIUM-FALCIPARUM MEROZOITES | STAGE | FULL-LENGTH | IMMUNOLOGY | Recombinant Fusion Proteins - immunology | Vaccines, DNA - chemical synthesis | Protein Kinases - genetics | Adjuvants, Immunologic - administration & dosage | Antigens, Protozoan - immunology | Protein Kinases - administration & dosage | Vaccines, DNA - immunology | Molecular Sequence Data | Growth Inhibitors - chemical synthesis | Macaca mulatta | Subtilisins - immunology | Plasmodium falciparum - immunology | Protozoan Proteins - genetics | Vaccines, DNA - administration & dosage | Calcium-Binding Proteins - immunology | Antigens, Protozoan - administration & dosage | Malaria Vaccines - immunology | Adjuvants, Immunologic - genetics | Antiprotozoal Agents - chemical synthesis | Antigens, Protozoan - genetics | Protozoan Proteins - administration & dosage | Growth Inhibitors - genetics | Subtilisins - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Rabbits | Antibodies, Protozoan - physiology | Membrane Proteins - genetics | Adjuvants, Immunologic - chemical synthesis | Membrane Proteins - immunology | Recombinant Fusion Proteins - chemical synthesis | Malaria Vaccines - chemical synthesis | Calcium-Binding Proteins - administration & dosage | Antiprotozoal Agents - immunology | Membrane Proteins - administration & dosage | Growth Inhibitors - immunology | Animals | Growth Inhibitors - administration & dosage | Malaria Vaccines - administration & dosage | Protein Kinases - immunology | Antiprotozoal Agents - administration & dosage | Recombinant Fusion Proteins - genetics | Subtilisins - genetics | Plasmodium falciparum - growth & development | Protozoan Proteins - immunology | Calcium-Binding Proteins - genetics | Malaria Vaccines - genetics
Journal Article
Biomaterials, ISSN 0142-9612, 2015, Volume 80, pp. 68 - 79
Abstract Targeted oral delivery of GFP fused with a GM1 receptor binding protein (CTB... 
Advanced Basic Science | Dentistry | Molecular farming | Chloroplasts | Cell-penetrating peptides | Protein drug delivery | MATERIALS SCIENCE, BIOMATERIALS | TRANSDUCTION DOMAIN | DENDRITIC CELLS | GM1 GANGLIOSIDE | ENGINEERING, BIOMEDICAL | PDX-1 PROTEIN | TOBACCO CHLOROPLASTS | GREEN FLUORESCENT PROTEIN | INHIBITOR FORMATION | IN-VIVO | ORAL DELIVERY | CHOLERA-TOXIN | Cell Line | Cell-Penetrating Peptides - genetics | Plant Cells - metabolism | Humans | Mice, Inbred C57BL | Bacterial Proteins - genetics | Cell-Penetrating Peptides - pharmacokinetics | Models, Molecular | Receptors, Cell Surface - metabolism | Green Fluorescent Proteins - genetics | Immune System - cytology | Bacterial Proteins - administration & dosage | Animals | Drug Delivery Systems - economics | Green Fluorescent Proteins - administration & dosage | Bacterial Proteins - pharmacokinetics | Recombinant Fusion Proteins - pharmacokinetics | Green Fluorescent Proteins - pharmacokinetics | Recombinant Fusion Proteins - genetics | Female | Cell-Penetrating Peptides - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Peptides | Dendritic cells | Fermentation | Gangliosides | Liver | Protein binding | Drugs | Medical colleges | Drug delivery systems | Patient compliance | Vehicles | Human | Proteins | PTD | Enzymes | Receptors | Plants (organisms) | Tags | cell-penetrating peptides | molecular farming | protein drug delivery
Journal Article
PloS one, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, p. e112802
...). Exogenous model antigens expressed by these modified bacteria as protein fusions with the bacterial enterotoxin ClyA resulted in their display on the surface of the carrier OMVs... 
Recombinant Fusion Proteins - immunology | Hemolysin Proteins - immunology | Species Specificity | Bacterial Vaccines - genetics | Hemolysin Proteins - genetics | Antigens, Bacterial - immunology | Th1 Cells - immunology | Antigens, Bacterial - genetics | Probiotics - chemistry | Hemolysin Proteins - administration & dosage | Cell Membrane - chemistry | Immunity, Cellular - drug effects | Antibodies, Bacterial - biosynthesis | Escherichia coli Proteins - administration & dosage | Female | Escherichia coli Proteins - immunology | Bacterial Outer Membrane Proteins - genetics | Recombinant Fusion Proteins - administration & dosage | Gene Expression | Immunization | Vaccines, Subunit | Bacterial Outer Membrane Proteins - immunology | Bacterial Outer Membrane Proteins - administration & dosage | Escherichia coli - immunology | Antigens, Bacterial - administration & dosage | Escherichia coli - chemistry | Animals | Bacterial Vaccines - administration & dosage | Bacterial Vaccines - immunology | Escherichia coli Proteins - genetics | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Vaccines, Synthetic | Cell Membrane - immunology | Mice | Mice, Inbred BALB C | Th1 Cells - cytology | Veterinary colleges | Drug delivery systems | Vaccination | Lymphocytes T | Vaccines | Kinases | Veterinary medicine | Immunity | Immunity (cell-mediated) | Nanoparticles | Proteins | Engineering | Vesicles | Immunology | E coli | Cell cycle | Bacteria | Immunity (humoral) | Immunomodulators | Public health | ClyA protein | Biomedical engineering | Immune system | Antigens | Pathogens | Immune response | Cytokines | Immunomodulation | Membrane vesicles | T cell receptors | Adaptive immunity | Carriers | Probiotics
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 3, pp. 524 - 532
Highlights ► This Phase 1 trial evaluated the safety and immunogenicity of an RSV (F) nanoparticle vaccine. ► The vaccine was well-tolerated and no related... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article